Cargando…
Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies
Here we propose a strategy allowing implementing efficient and practicable large-scale seroepidemiological studies for Zika Virus (ZIKV). It combines screening by a commercial NS1 protein-based Zika IgG ELISA, and confirmation by a cytopathic effect-based virus neutralization test (CPE-based VNT). I...
Autores principales: | Nurtop, Elif, Villarroel, Paola Mariela Saba, Pastorino, Boris, Ninove, Laetitia, Drexler, Jan-Felix, Roca, Yelin, Gake, Bouba, Dubot-Peres, Audrey, Grard, Gilda, Peyrefitte, Christophe, Priet, Stéphane, de Lamballerie, Xavier, Gallian, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307276/ https://www.ncbi.nlm.nih.gov/pubmed/30587193 http://dx.doi.org/10.1186/s12985-018-1105-5 |
Ejemplares similares
-
Correction to: Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies
por: Nurtop, Elif, et al.
Publicado: (2019) -
Zika virus epidemiology in Bolivia: A seroprevalence study in volunteer blood donors
por: Saba Villarroel, Paola Mariela, et al.
Publicado: (2018) -
Low seroprevalence of Zika virus in Cameroonian blood donors
por: Gake, Bouba, et al.
Publicado: (2017) -
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors
por: Gallian, Pierre, et al.
Publicado: (2020) -
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021
por: Gallian, Pierre, et al.
Publicado: (2023)